Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study

Mathias Wolters,Martin Krastel,Thorben Winkler,Hamza Idais,Mehrdad Mazdak,Hossein Tezval,Markus A. Kuczyk,Christoph-A. J. von Klot

DOI: https://doi.org/10.1038/s41391-024-00836-w

2024-04-25

Prostate Cancer and Prostatic Diseases

Abstract:Water vapor thermal therapy (Rezum) is a minimally invasive treatment for benign prostatic enlargement (BPE). Studies reporting urodynamic results regarding the procedure are rare. Our study aimed to assess the effectiveness of Rezum on urinary outcome parameters in a consecutive series of patients and compare urodynamic data before and after treatment.

oncology,urology & nephrology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the efficacy of water vapor thermotherapy (Rezum) in patients with benign prostatic hyperplasia (BPE), especially its impact on urodynamic parameters. Specifically, the study aims to:

1. **Evaluate the effectiveness of Rezum treatment**: By analyzing the changes in patients' symptom scores (such as IPSS and IPSS - QoL), maximum urinary flow rate (Qmax), post - void residual urine volume (PVR), prostate volume (PVol) and other indicators, to measure the improvement effect of Rezum treatment on urinary tract symptoms.

2. **Compare urodynamic data before and after treatment**: The study pays special attention to the change of bladder outlet obstruction (BOO) index (BOOI) to understand the specific impact of Rezum on bladder outlet obstruction.

3. **Provide detailed urodynamic data**: This is one of the few current studies on Rezum treatment that provides detailed urodynamic data before and after treatment, which helps to better understand the improvement mechanism of Rezum on urinary tract function.

### Core problems of the paper
The core problem of the paper is to verify whether Rezum treatment can significantly improve the urinary tract symptoms of BPE patients and reduce bladder outlet obstruction. In addition, the study also explores the differences in the efficacy of Rezum treatment for patients with different prostate volumes.

---

### Formula summary
The formulas involved in the paper include:

1. **Voiding Efficiency (VE)**:
$$
VE=\left(\frac{\text{Urination volume}}{\text{Bladder capacity}}\right)\times100[\%]
$$

2. **Bladder Outlet Obstruction Index (BOOI)**:
$$
BOOI = P_{\text{det}Q_{\text{max}}} - 2Q_{\text{max}}[\text{cm H}_2\text{O}]
$$
where:
- $P_{\text{det}Q_{\text{max}}}$: Detrusor pressure at maximum urinary flow (cm H₂O)
- $Q_{\text{max}}$: Maximum urinary flow rate (ml/s)

3. **Bladder Contractility Index (BCI)**:
$$
BCI = P_{\text{det}Q_{\text{max}}} + 5Q_{\text{max}}
$$

---

### Summary
Through a retrospective single - center study, the paper evaluates the effect of Rezum treatment in relieving BPE - related symptoms and improving urodynamic parameters. The study shows that Rezum not only significantly improves patients' symptom scores and urinary flow rates, but also significantly reduces the bladder outlet obstruction index (BOOI), thus providing further evidence support for minimally invasive treatment of BPE.